Pfizer Inc. (BIT:1PFE)

Italy flag Italy · Delayed Price · Currency is EUR
23.24
+0.09 (0.39%)
Last updated: Feb 11, 2026, 3:57 PM CET
Market Cap131.91B -9.0%
Revenue (ttm)53.30B -1.6%
Net Income6.62B -3.2%
EPS1.16 -3.4%
Shares Outn/a
PE Ratio19.93
Forward PE9.27
Dividend1.49 (6.43%)
Ex-Dividend DateJan 22, 2026
Volume75,536
Average Volume7,847
Open23.13
Previous Close23.15
Day's Range23.10 - 23.24
52-Week Range18.73 - 25.42
Betan/a
RSI63.70
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Borsa Italiana
Ticker Symbol 1PFE
Full Company Profile

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD Financial Statements